Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
Clinical trial NCT04526704 · COMPLETED
Trial details
- NCT number
- NCT04526704
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2023-07-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.